SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000921895-09-000097
Filing Date
2009-01-12
Accepted
2009-01-12 12:36:24
Documents
4

Document Format Files

Seq Description Document Type Size
1 sc13da507422003_01092009.htm SC 13D/A 279043
2 JOINT FILING AND SOLICITATION AGREEMENT ex991to13da507422003_010909.htm EX-99.1 50545
3 FORM OF INDEMNIFICATION LETTER ex992to13da507422003_010909.htm EX-99.2 23928
4 POWERS OF ATTORNEY ex993to13da507422003_010909.htm EX-99.3 33901
  Complete submission text file 0000921895-09-000097.txt   389372
Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611
Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 6282 Investment Advice

Mailing Address 1301 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1301 HARBOR BAY PARKWAY . ALAMEDA CA 94502 5107487150
AVIGEN INC \DE (Subject) CIK: 0000932903 (see all company filings)

IRS No.: 133647119 | State of Incorp.: DE | Fiscal Year End: 1121
Type: SC 13D/A | Act: 34 | File No.: 005-48313 | Film No.: 09521097
SIC: 2835 In Vitro & In Vivo Diagnostic Substances